AskBio Advances Parkinson's Research Amidst Growing Global Impact
As Parkinson’s Awareness Month concludes, the focus on advancing research for Parkinson’s disease remains critical. With nearly 10 million people affected worldwide, the disease's impact is significant and growing. AskBio, a biotechnology company, is at the forefront of research efforts aimed at developing new treatment alternatives. Despite the absence of a cure or treatments that slow disease progression, AskBio is exploring innovative approaches, including gene therapy, to address the challenges faced by those living with Parkinson’s. The company emphasizes the importance of moving beyond symptom management to potentially altering disease progression. Current research efforts are bolstered by advancements in molecular neuroscience, gene delivery, and clinical trial design, which allow for more targeted investigations into the disease's pathways.